Page last updated: 2024-08-21

pyrazines and Hearing Loss, Sensorineural

pyrazines has been researched along with Hearing Loss, Sensorineural in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bin, L; Chen, J; Guan, G; He, X; Tang, X1
Chim, CS; Wong, LG1

Other Studies

2 other study(ies) available for pyrazines and Hearing Loss, Sensorineural

ArticleYear
Identifying the mechanisms underlying the protective effect of tetramethylpyrazine against cisplatin‑induced in vitro ototoxicity in HEI‑OC1 auditory cells using gene expression profiling.
    Molecular medicine reports, 2020, Volume: 22, Issue:6

    Topics: Abietanes; Animals; Apoptosis; Cell Line; Cell Proliferation; China; Cisplatin; Databases, Genetic; Gene Expression Profiling; Hearing Loss, Sensorineural; Humans; Mice; Ototoxicity; Pyrazines; Signal Transduction

2020
Deafness associated with the use of Bortezomib in multiple myeloma.
    Acta oncologica (Stockholm, Sweden), 2008, Volume: 47, Issue:2

    Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Fatal Outcome; Female; Hearing Loss, Sensorineural; Humans; Immunoglobulin A; Multiple Myeloma; Pyrazines; Risk Factors

2008